Global initiative for chronic obstructive lung diseases (GOLD): time to act

Pauwels R.

Source: Eur Respir J 2001; 18: 901-902
Journal Issue: December
Disease area: Airway diseases

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pauwels R.. Global initiative for chronic obstructive lung diseases (GOLD): time to act. Eur Respir J 2001; 18: 901-902

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003



Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Chronic obstructive pulmonary disease: How good is GOLD on its own?!
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013

Chronic obstructive pulmonary disease (COPD) – patient‘s perspective
Source: Eur Respir J 2007; 30: Suppl. 51, 168s
Year: 2007

Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV
Source: Eur Respir J 2008; 32: 42-52
Year: 2008



Programme organisation: what and how can we do better?
Source: Annual Congress 2007 - PG20 - Pulmonary rehabilitation: an update according to the new ATS/ERS guidelines
Year: 2007


Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013


Quality control of lung function testing in the registry for patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Lung function II
Year: 2007


A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Obesity and impairments in chronic obstruction pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

Validity of chronic obstructive pulmonary disease simulation using straws
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016


Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Chronic obstructive lung diseases
Source: Eur Respir Monogr 2014; 66: 199-217
Year: 2014


Common airway variants and chronic obstructive pulmonary disease
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015

Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002

Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006


Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005

Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016